Skip to content
  • About EUnetHTA 21
    • History of EUnetHTA
      • JA 3 Archive (2016-2021)
        • Early Dialogues
          • Early Dialogues for Pharmaceuticals
          • Early Dialogues for Medical Devices
          • Parallel Consultations
        • POP Database
        • EVIDENT Database
        • Events
          • 2021 EUnetHTA Forum
          • 2020 EUnetHTA Forum
          • 2019 EUnetHTA Forum
          • 2018 EUnetHTA Forum
          • 2017 EUnetHTA Forum
        • EUnetHTA and the HTA Network
        • Organisation
          • The Executive Board
          • EUnetHTA Network
      • JA 2 Archive (2012-2015)
      • JA 1 Archive (2010-2012)
      • EUnetHTA Collaboration (2009)
      • EUnetHTA Project (2006-2008)
      • EUnetHTA Magazine
      • Acronyms
    • Vision, Mission, and Values
    • The Secretariat
    • Consortium Executive Board (CEB)
    • Committee for Scientific Quality & Consistency (CSCQ)
    • Conflict of Interest Committee (COIC)
    • Future Model of Cooperation (FMC) – White Paper
  • Joint HTA Work
    • Joint Clinical Assessments (JCA)
      • Assessment Archive (2006-2021)
    • Joint Scientific Consultations (JSC)
      • Parallel Consultation
      • PLEG
    • COVID-19 Response
      • Diagnostics
      • Treatments
      • Useful Links
  • Tools
    • HTA Core Model®
    • Methodology
    • EUnetHTA Companion Guide
    • REQueST® Tool
    • Partial use of GRADE and common phrases
    • PICO FAQ
    • Templates for Pharma and Med. Devices
  • Get Involved
    • Public Consultation
    • Events
    • Online Questionnaires
Menu
  • About EUnetHTA 21
    • History of EUnetHTA
      • JA 3 Archive (2016-2021)
        • Early Dialogues
          • Early Dialogues for Pharmaceuticals
          • Early Dialogues for Medical Devices
          • Parallel Consultations
        • POP Database
        • EVIDENT Database
        • Events
          • 2021 EUnetHTA Forum
          • 2020 EUnetHTA Forum
          • 2019 EUnetHTA Forum
          • 2018 EUnetHTA Forum
          • 2017 EUnetHTA Forum
        • EUnetHTA and the HTA Network
        • Organisation
          • The Executive Board
          • EUnetHTA Network
      • JA 2 Archive (2012-2015)
      • JA 1 Archive (2010-2012)
      • EUnetHTA Collaboration (2009)
      • EUnetHTA Project (2006-2008)
      • EUnetHTA Magazine
      • Acronyms
    • Vision, Mission, and Values
    • The Secretariat
    • Consortium Executive Board (CEB)
    • Committee for Scientific Quality & Consistency (CSCQ)
    • Conflict of Interest Committee (COIC)
    • Future Model of Cooperation (FMC) – White Paper
  • Joint HTA Work
    • Joint Clinical Assessments (JCA)
      • Assessment Archive (2006-2021)
    • Joint Scientific Consultations (JSC)
      • Parallel Consultation
      • PLEG
    • COVID-19 Response
      • Diagnostics
      • Treatments
      • Useful Links
  • Tools
    • HTA Core Model®
    • Methodology
    • EUnetHTA Companion Guide
    • REQueST® Tool
    • Partial use of GRADE and common phrases
    • PICO FAQ
    • Templates for Pharma and Med. Devices
  • Get Involved
    • Public Consultation
    • Events
    • Online Questionnaires
Linkedin Twitter Envelope

RCR23 – Aspirin

Home
RCR23 – Aspirin

RCR23: Aspirin

Access all versions of the report here:

RCR23: Aspirin – Version 9: October 2021

RCR23: Aspirin – Version 8: September 2021

RCR23: Aspirin – Version 7: August 2021

RCR23: Aspirin – Version 6: July 2021

RCR23: Aspirin – Version 5: June 2021

RCR23: Aspirin – Version 4: May 2021

RCR23: Aspirin – Version 3: April 2021

RCR23: Aspirin – Version 2: March 2021

RCR23: Aspirin – Version 1: February 2021

OUR NETWORK

  • EUnetHTA Network
  • JA 3 (2016-2021)
  • JA 2 Archive (2012-2015)
  • JA 1 Archive (2010-2012)
  • EUnetHTA Collaboration (2009)
  • EUnetHTA Project (2006-2008)
Menu
  • EUnetHTA Network
  • JA 3 (2016-2021)
  • JA 2 Archive (2012-2015)
  • JA 1 Archive (2010-2012)
  • EUnetHTA Collaboration (2009)
  • EUnetHTA Project (2006-2008)

CAREERS

  • Work with EUnetHTA
Menu
  • Work with EUnetHTA

HELP

eunethta@zinl.nl

CONTACT US

  • Media and Press
  • Disclaimer
  • Reusing our content
  • Terms of use
  • Privacy Policy
Menu
  • Media and Press
  • Disclaimer
  • Reusing our content
  • Terms of use
  • Privacy Policy

This website was produced under the Third EU Health Programme through a service contract with the European Health and Digital Executive Agency (HaDEA) acting under the mandate from the European Commission. The information and views set out in this website are those of the author(s) and do not necessarily reflect the official opinion of the Commission/Executive Agency. The Commission/Executive Agency do not guarantee the accuracy of the data included in this website. Neither the Commission/Executive Agency nor any person acting on the Commission’s/Executive Agency’s behalf may be held responsible for the use which may be made of the information contained therein.

©2021 EUnetHTA All rights reserved.

This website uses cookies to ensure you get the best experience on our website. By using the website you agree to our Privacy Policy and our Terms of Use.
Accept and Close